Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese

Genes and Immunity

Volumn 8, Issue 6, 2007, Pages 475-479

  Chu, S F ^a   Tam, C M ^b   Wong, H S ^a   Kam, K M ^c   Lau, Y L ^a   Chiang, A K S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c Public Health Laboratory Centre   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; FUNCTIONAL GENOMICS; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POPULATION GENETICS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CCL5; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HONG KONG; HUMANS; LINKAGE DISEQUILIBRIUM; MACROPHAGE INFLAMMATORY PROTEINS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS;

EID: 34548403040     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364412     Document Type: Article

References (24)

1. World Health Organization. Regional Office for the Western Pacific. Regional strategic plan to stop TB in the Western Pacific, Manila, Philippines, 2000.
2. Murray CJ, Styblo K, Rouillon. A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-24.
3. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1942; 47: 549-574.
4. Tso HW, Lau YL, Tam CM, Wong HS, Chiang AK. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 2004; 190: 913-919.
5. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005; 6: 358-363.
6. Blackwell JM, Black GF, Peacock CS, Miller EN, Sibthorpe D, Gnananandha D et al. Immunogenetics of leishmanial and mycobacterial infections: The Belem Family Study. Philos Trans R Soc Lond B Biol Sci 1997; 352: 1331-1345.
7. Jamieson SE, Miller EN, Black GF, Peacock CS, Cordell HJ, Howson JM et al. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 2004; 5: 46-57.
8. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 1996; 156: 2095-2103.
9. Lima MF, Zhang Y, Villalta F. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell Mol Biol (Noisy-le-Grand) 1997; 43: 1067-1076.
10. Chensue SW, Warmington KS, Allenspach EJ, Lu B, Gerard C, Kunkel SL et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 1999; 163: 165-173.
11. Ulrichs T, Kosmiadi GA, Trusov V, Jorg S, Pradl L, Titukhina M et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol 2004; 204: 217-228.
12. Co DO, Hogan LH, Kim SI, Sandor M. Mycobacterial granulomas: Keys to a long-lasting host-pathogen relationship. Clin Immunol 2004; 113 130-136.
13. Saukkonen JJ, Bazydlo B, Thomas M, Strieter RM, Keane J, Kornfeld H. Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 2002; 70: 1684-1693.
14. Rovin BH, Lu L, Saxena, R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344-348.
15. Nickel RG, Casolaro V, Wahn U, Beyer K; Barnes KC, Plunkett BS et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000; 164: 1612-1616.
16. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96: 4581-4585.
17. McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000; 14: 2671-2678.
18. An P, Nelson GW, Wang L, Donfield S, Goedert JJ, Phair J et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002; 99: 10002-10007.
19. Gonzalez E, Dhanda R, Bamshad M, Mummidi S, Geevarghese R, Catano G et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: Impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci USA 2001; 98: 5199-5204.
20. Sadek MI, Sada E, Toossi Z, Schwander SK, Rich EA. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 1998; 19: 513-521.
21. Kurashima K, Mukaida N, Fujimura M, Yasui M, Nakazumi Y, Matsuda T et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 1997; 155: 1474-1477.
22. Appay V, Rowland-Jones SL. RANTES: A versatile and controversial chemokine. Trends Immunol 2001; 22: 83-87.
23. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montano M et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 2005; 202: 1649-1658.
24. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233-239.